Guardant Health, Inc.
Musa Tariq (Director) sells GH shares
AI-generated summary
Director Musa Tariq had 250 shares from an RSU vesting. They also sold 116 shares at an average price of $165.88 for a total value of $19,242.08. Following these transactions, the insider directly held 11,583 shares. The sale was made under a Rule 10b5-1 trading plan.
Key facts
- Insider
- Musa Tariq · Director
Rule 10b5-1 plan
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | M · exercise or conversion of a derivative | +250 | $0.00 | $0.00 | 11,699 | Direct |
| Oct 16, 2026 | S · open-market sale | −116 | $165.88 | $19,242.08 | 11,583 | Direct |
| Oct 15, 2026 | M · exercise or conversion of a derivativeRestricted Stock UnitsFootnotes F1, F2 | −250 | $0.00 | $0.00 | 1,250 | Direct |
Footnotes
- F1 The restricted stock unit award granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on March 15, 2024 and the remaining 75% vests monthly for the three-year period thereafter.
- F2 Not applicable for Restricted Stock Units.
More GH filings
- 8-K
Filed Nov 3, 2026
- 4
Filed Oct 22, 2026
- 4
Filed Oct 19, 2026
- 144
Filed Oct 16, 2026
- 4
Filed Oct 15, 2026
- 144
Filed Oct 14, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.